Sponsored Content

Asia Number One! Glac Totipro®Postbiotics PE0401 Named WINNER at NutraIngredients Asia Awards 2023!

17 Oct 2023

New Proud Achievement in the World of Postbiotics! Totipro®Postbiotics PE0401 has earned recognition as the FIRST in the world to excel in the "Ingredient: Microbiome Modulation" category, specifically for gastrointestinal function enhancement!

New Proud Achievement in the World of Postbiotics! Totipro®Postbiotics PE0401 has earned recognition as the FIRST in the world to excel in the "Ingredient: Microbiome Modulation" category, specifically for gastrointestinal function enhancement! Glac Totipro® Postbiotic PE0401 is a probiotics fermentation essence derived from four signature probiotic single strains (Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Bifidobacterium longum BLI-02, Lactobacillus acidophilus TYCA06). It combines the benefits of probiotics, prebiotics, and nutrients, making it a versatile ingredient with a wide range of food and beverage applications. Its unique composition has been extensively studied in human trials and animal studies, consistently demonstrating its remarkable benefits.

Asia Number One! Glac Totipro®Postbiotics PE0401 Named WINNER at NutraIngredients Asia Awards 2023!
Totipro® Postbiotics PE0401:Intelligent Choice of Health

Established in 2008, Glac is a biotech company that adheres to the principles of "Science, Quality, Sincerity, and Uniqueness." Initially, our focus was on probiotic research, but our research and development (R&D) team soon discovered the crucial role of fermented probiotics, known as postbiotics, in enhancing both gut and immune systems. Since 2009, we have been unwavering in our commitment to researching and developing postbiotics, leading to the discovery of our unique fermented probiotic essence, Totipro® Postbiotics. Totipro® Postbiotics PE0401 has demonstrated remarkable effects in repairing intestinal mucosal cells and balancing intestinal flora, resulting in significant improvements in digestive function and relief from gastrointestinal discomfort and constipation.

Through these studies, Glac Totipro®Postbiotic PE0401 has shown its ability to promote gastrointestinal digestion and motility, as well as support the colonization and growth of beneficial probiotics in the intestine. It is enriched with essential nutrients for the human body, including oligosaccharides, small molecule amino acids, digestive enzymes, trace minerals, and hyaluronic acid. These components contribute to overall health and well-being.

✅ Optimize gut microbiota.

✅ Promote bowel movements.

✅ Support the immune system.

✅ Improve metabolic functions.

Furthermore, Glac Totipro®Postbiotic PE0401 has been found to enhance the production of immune factors such as TGF-b and IL-10 in the blood, which play crucial roles in maintaining a healthy immune system. This remarkable feature further establishes its effectiveness in improving overall human health.

Given its exceptional properties, extensive research support, successful market engagement, and the acquisition of invention patents, Glac Totipro®Postbiotic PE0401 stands as a deserving candidate for this award. Its unique composition and proven benefits position it as a game-changer in the field, offering innovative solutions to meet the evolving needs of consumers in the health and wellness industry.

Regarding the worldwide market prospects of Totipro®Postbiotics PE0401, we have witnessed remarkable commercial triumph and robust engagement in our designated sales regions. Specifically, we have garnered substantial success in our primary markets, which encompass China, South East Asia, Europe, and Australia. In terms of safeguarding our intellectual property on a global scale, we have secured patent protection in key regions, including 3 patents in the United States, 3 in China, 3 in Taiwan, and global coverage through 1 World PCT protection. With these achievements, we are primed to make our foray into the international ingredient market.

To learn more, please drop us a line on [email protected]

Read More

Related news

PharmaLinea’s iron supplement delivers improvements in  hemoglobin comparable to ferrous sulfate with fewer side  effects

PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects

23 Feb 2026

PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.

Read more 
LomaChelateX® – power in magnesium bisglycinate

LomaChelateX® – power in magnesium bisglycinate

12 Feb 2026

Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.

Read more 
Fucoidan leader reports record production

Fucoidan leader reports record production

22 Jan 2026

The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.

Read more 
India Honours Ashwagandha with Commemorative  Postal Stamp at WHO Global Summit

India Honours Ashwagandha with Commemorative Postal Stamp at WHO Global Summit

6 Jan 2026

HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...

Read more 
PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

22 Dec 2025

PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...

Read more 
FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

11 Dec 2025

Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...

Read more 
dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

11 Dec 2025

Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025  dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...

Read more 
Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

11 Dec 2025

Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...

Read more 
Fucoidan specialist takes out top international health award

Fucoidan specialist takes out top international health award

4 Dec 2025

Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.

Read more 
Prayon inaugurates its new SHMP production unit in Engis

Prayon inaugurates its new SHMP production unit in Engis

1 Dec 2025

Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market

Read more